NEW YORK, September 5, 2006 -- For forty years, the gold standard for treating a single, small tumor in the kidney has been to remove the entire kidney. A retrospective study, which appears in the ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

The probability of surgical success with telesurgery for radical prostatectomy and partial nephrectomy for small renal masses was non-inferior to local robotic surgery in a small randomized trial. The ...

Nephron-sparing management is one strategy to reduce risks, according to investigators. Older age is significantly associated with greater kidney function decline after radical nephrectomy in patients ...

Nephron-sparing surgery may not reduce the risk for later kidney failure in patients with kidney cancer and stage 4 CKD. Despite the promise of nephron-sparing, new study findings suggest that the ...

Biomarker analysis from the phase 3 CheckMate 9ER trial of nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma (aRCC). Evolution of systemic therapy from 2015 to 2019 for older ...

Stage 2 kidney cancer involves a tumor over 7 cm, confined to the kidney, often treated surgically. Diagnosis includes imaging, blood tests, and possibly biopsy to confirm cancer type and stage.

Resistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Children's Research Hospital scientists demonstrated that in bilateral Wilms tumor ...

Please provide your email address to receive an email when new articles are posted on . NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular ...

Please provide your email address to receive an email when new articles are posted on . Lower rates of adverse outcomes were linked to higher technical skill Surgeons with higher scores had lower ...